Quick Answer
Edwards Lifesciences Corp reported Cash And Cash Equivalents At Carrying Value of $2.94 billion for the year ending 2025.
- Edwards Lifesciences Corp showed a decrease of -3.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2010 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 19 years of available data (2010 to 2025), Edwards Lifesciences Corp's Cash And Cash Equivalents At Carrying Value has grown by 641.7%.
- Historical annual values: Fiscal year 2025: $2.94 billion | Fiscal year 2024: $3.05 billion | Fiscal year 2023: $1.13 billion | Fiscal year 2022: $769.00 million | Fiscal year 2021: $862.80 million | Fiscal year 2020: $1.18 billion | Fiscal year 2019: $1.18 billion | Fiscal year 2018: $714.10 million | Fiscal year 2017: $818.30 million | Fiscal year 2016: $930.10 million | Fiscal year 2015: $718.40 million | Fiscal year 2014: $653.80 million | Fiscal year 2013: $420.40 million | Fiscal year 2012: $310.90 million | Fiscal year 2011: $171.20 million | Fiscal year 2011: $244.00 million | Fiscal year 2011: $175.60 million | Fiscal year 2011: $325.20 million | Fiscal year 2010: $396.10 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: